Annual total expenses:
$37.18B+$287.00M(+0.78%)Summary
- As of today (May 20, 2025), NVS annual total expenses is $37.18 billion, with the most recent change of +$287.00 million (+0.78%) on December 31, 2024.
- During the last 3 years, NVS annual total expenses has risen by +$3.26 billion (+9.61%).
- NVS annual total expenses is now -23.49% below its all-time high of $48.59 billion, reached on December 31, 2011.
Performance
NVS Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$8.96B-$1.07B(-10.68%)Summary
- As of today (May 20, 2025), NVS quarterly total expenses is $8.96 billion, with the most recent change of -$1.07 billion (-10.68%) on March 31, 2025.
- Over the past year, NVS quarterly total expenses has increased by +$210.00 million (+2.40%).
- NVS quarterly total expenses is now -35.55% below its all-time high of $13.90 billion, reached on December 31, 2011.
Performance
NVS Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
NVS Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.8% | +2.4% |
3 y3 years | +9.6% | -10.1% |
5 y5 years | -6.1% | -10.1% |
NVS Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +9.6% | -17.5% | +6.3% |
5 y | 5-year | -6.5% | +9.6% | -17.5% | +142.7% |
alltime | all time | -23.5% | +157.5% | -35.5% | +173.3% |
NVS Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $8.96B(-10.7%) |
Dec 2024 | $37.18B(+0.8%) | $10.03B(+5.1%) |
Sep 2024 | - | $9.54B(+7.8%) |
Jun 2024 | - | $8.86B(+1.3%) |
Mar 2024 | - | $8.75B(-4.9%) |
Dec 2023 | $36.89B(+3.9%) | $9.19B(-11.0%) |
Sep 2023 | - | $10.33B(+15.6%) |
Jun 2023 | - | $8.94B(+6.0%) |
Mar 2023 | - | $8.43B(-8.5%) |
Dec 2022 | $35.52B(+4.7%) | $9.21B(+2.8%) |
Sep 2022 | - | $8.96B(-17.5%) |
Jun 2022 | - | $10.86B(+9.0%) |
Mar 2022 | - | $9.96B(+170.0%) |
Dec 2021 | $33.92B(-14.7%) | $3.69B(-63.6%) |
Sep 2021 | - | $10.13B(+3.3%) |
Jun 2021 | - | $9.81B(-4.5%) |
Mar 2021 | - | $10.28B(-1.0%) |
Dec 2020 | $39.75B(+0.4%) | $10.39B(+2.6%) |
Sep 2020 | - | $10.13B(+9.2%) |
Jun 2020 | - | $9.27B(-7.0%) |
Mar 2020 | - | $9.96B(-8.5%) |
Dec 2019 | $39.59B(+5.0%) | $10.89B(+7.6%) |
Sep 2019 | - | $10.12B(+8.2%) |
Jun 2019 | - | $9.36B(+1.6%) |
Mar 2019 | - | $9.21B(-12.5%) |
Dec 2018 | $37.70B(+8.6%) | $10.54B(+15.2%) |
Sep 2018 | - | $9.15B(-0.8%) |
Jun 2018 | - | $9.22B(+4.9%) |
Mar 2018 | - | $8.79B(+104.9%) |
Dec 2017 | $34.70B(-15.7%) | $4.29B(-58.5%) |
Sep 2017 | - | $10.34B(+1.2%) |
Jun 2017 | - | $10.21B(+3.6%) |
Mar 2017 | - | $9.86B(-11.6%) |
Dec 2016 | $41.17B(-0.6%) | $11.15B(+10.7%) |
Sep 2016 | - | $10.07B(-4.9%) |
Jun 2016 | - | $10.59B(+13.1%) |
Mar 2016 | - | $9.36B(-15.9%) |
Dec 2015 | $41.41B(-2.7%) | $11.13B(+8.5%) |
Sep 2015 | - | $10.25B(-3.4%) |
Jun 2015 | - | $10.62B(+12.7%) |
Mar 2015 | - | $9.42B(-14.4%) |
Dec 2014 | $42.55B(+1.9%) | $11.00B(+4.2%) |
Sep 2014 | - | $10.56B(-1.9%) |
Jun 2014 | - | $10.77B(+5.4%) |
Mar 2014 | - | $10.22B(-9.6%) |
Dec 2013 | $41.73B(+3.1%) | $11.29B(+9.2%) |
Sep 2013 | - | $10.35B(+1.0%) |
Jun 2013 | - | $10.25B(-9.4%) |
Mar 2013 | - | $11.31B(+67.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | $40.46B(-16.7%) | $6.76B(-39.0%) |
Sep 2012 | - | $11.09B(-3.0%) |
Jun 2012 | - | $11.43B(+2.3%) |
Mar 2012 | - | $11.18B(-19.6%) |
Dec 2011 | $48.59B(+21.4%) | $13.90B(+15.0%) |
Sep 2011 | - | $12.08B(+2.4%) |
Jun 2011 | - | $11.80B(+9.1%) |
Mar 2011 | - | $10.81B(-9.9%) |
Dec 2010 | $40.03B(+14.0%) | $12.00B(+17.2%) |
Sep 2010 | - | $10.23B(+14.2%) |
Jun 2010 | - | $8.96B(+1.3%) |
Mar 2010 | - | $8.85B(-15.8%) |
Dec 2009 | $35.12B(+4.5%) | $10.51B(+21.4%) |
Sep 2009 | - | $8.66B(+3.3%) |
Jun 2009 | - | $8.38B(+7.4%) |
Mar 2009 | - | $7.80B(-10.0%) |
Dec 2008 | $33.62B(+4.5%) | $8.67B(-0.3%) |
Sep 2008 | - | $8.70B(+1.9%) |
Jun 2008 | - | $8.53B(+10.4%) |
Mar 2008 | - | $7.73B(-21.7%) |
Dec 2007 | $32.17B(+17.1%) | $9.86B(+26.9%) |
Sep 2007 | - | $7.78B(+5.7%) |
Jun 2007 | - | $7.36B(+4.5%) |
Mar 2007 | - | $7.04B(-11.2%) |
Dec 2006 | $27.46B(+18.1%) | $7.93B(+12.5%) |
Sep 2006 | - | $7.04B(+9.3%) |
Jun 2006 | - | $6.44B(+5.8%) |
Mar 2006 | - | $6.09B(+24.6%) |
Dec 2005 | $23.25B(+9.9%) | $4.89B(-25.9%) |
Sep 2005 | - | $6.60B(+9.6%) |
Jun 2005 | - | $6.02B(+6.4%) |
Mar 2005 | - | $5.66B(+3.0%) |
Dec 2004 | $21.16B(+9.7%) | $5.50B(+2.9%) |
Sep 2004 | - | $5.34B(+3.1%) |
Jun 2004 | - | $5.18B(+0.7%) |
Mar 2004 | - | $5.14B(-5.5%) |
Dec 2003 | $19.30B(+22.2%) | $5.44B(+14.8%) |
Sep 2003 | - | $4.74B(+0.0%) |
Jun 2003 | - | $4.74B(+8.5%) |
Mar 2003 | - | $4.37B(+4.4%) |
Dec 2002 | $15.79B(+9.3%) | $4.18B(+9.6%) |
Sep 2002 | - | $3.82B(-8.2%) |
Jun 2002 | - | $4.16B(+24.4%) |
Dec 2001 | $14.44B(-16.6%) | - |
Jun 2001 | - | $3.34B(+1.9%) |
Dec 2000 | $17.30B(+9.7%) | - |
Jun 2000 | - | $3.28B |
Dec 1999 | $15.78B(-12.4%) | - |
Dec 1998 | $18.01B | - |
FAQ
- What is Novartis AG annual total expenses?
- What is the all time high annual total expenses for Novartis AG?
- What is Novartis AG annual total expenses year-on-year change?
- What is Novartis AG quarterly total expenses?
- What is the all time high quarterly total expenses for Novartis AG?
- What is Novartis AG quarterly total expenses year-on-year change?
What is Novartis AG annual total expenses?
The current annual total expenses of NVS is $37.18B
What is the all time high annual total expenses for Novartis AG?
Novartis AG all-time high annual total expenses is $48.59B
What is Novartis AG annual total expenses year-on-year change?
Over the past year, NVS annual total expenses has changed by +$287.00M (+0.78%)
What is Novartis AG quarterly total expenses?
The current quarterly total expenses of NVS is $8.96B
What is the all time high quarterly total expenses for Novartis AG?
Novartis AG all-time high quarterly total expenses is $13.90B
What is Novartis AG quarterly total expenses year-on-year change?
Over the past year, NVS quarterly total expenses has changed by +$210.00M (+2.40%)